SCHEMBL5869876

SCHEMBL5869876

CC(C)CC(C(=O)O)N(CCc1cccs1)CC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.42
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PKM P14618 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leucine SCHEMBL7424226 0.82 SLC7A5 (0.40) CYP2C19POLBTDP1
SCHEMBL7402628 0.82 CYP2C19 (0.44) CYP2C19POLBTDP1PKMALDH1A1
SCHEMBL5870039 0.80 DRD2 (0.42)
SCHEMBL5870171 0.78 KMT2A (0.37) POLBALDH1A1
SCHEMBL5869881 0.75 SIGMAR1 (0.46) CYP2C19ALDH1A1
SCHEMBL8256609 0.71 LMNA (0.43) ALDH1A1
SCHEMBL5869768 0.71 LMNA (0.43) ALDH1A1
SCHEMBL7383855 0.69 CYP2C19 (0.44) CYP2C19POLBTDP1PKMALDH1A1
SCHEMBL5870149 0.69 RAB9A (0.45) PKM
SCHEMBL8249703 0.69 RAB9A (0.45) PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045532-B2 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-05-16 US disclosed
US-6632830-B1 Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder MILLENNIUM PHARMACEUTICALS, INC. 2003-10-14 US disclosed